Tian Wang
Investor Relations Contact at Beijing Mabworks Biotech Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Feng Li | M | 52 |
Beijing Mabworks Biotech Co., Ltd.
 Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 13 years |
| Bo Yan Zhang | M | 59 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 years |
| Wen Qi Hu | M | 62 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 years |
| Ren Yu Li | M | 63 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 years |
| Yiu Leung Cheung | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 years |
| Tao Zhu | M | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 years |
| Jin Jin Liang | M | 55 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 5 years |
| Yan Qi | F | 54 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 17 years |
| Pei Ye | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 years |
| Hui Fang Liu | M | 64 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 12 years |
| Richard Dearlove | M | 79 |
University of London
| 10 years |
| Jing Zhang | F | 42 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 11 years |
| Ting Li | F | 35 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 4 years |
| Zhan Chao Liang | M | 40 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 8 years |
| Wing Sze Yu | F | 41 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Tong Li | F | 49 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 7 years |
| Qi Li | M | 44 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Xin Qu | F | 61 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Christine Yip | F | - |
University of London
| 4 years |
| Ziyang Long | M | 36 |
University of London
| 3 years |
| Hugo Cugnet | M | - |
University of London
| 3 years |
| Darren Chan | M | - |
University of London
| 4 years |
| Giacomo Eskenazi | M | - |
Newcastle University
| 4 years |
| Weili Tan | M | - |
University of London
| 2 years |
| Michael Bryan | M | - |
Newcastle University
| 3 years |
| Daniel Sykes | M | - |
Newcastle University
| 4 years |
| Benjamin Tubbs | M | - |
Newcastle University
| 3 years |
| Yu Man Cheung | M | 41 |
University of London
| 3 years |
| Joel Liew | M | - |
University of London
| 4 years |
| Chris Wolfe-Elder | M | - |
University of London
| 3 years |
| Melissa Josephine Susantio | F | 33 |
University of London
| 4 years |
| Chuan Yee Keh | M | 30 |
Newcastle University
| 4 years |
| Cassie Ren | F | - |
Newcastle University
| 2 years |
| James Merryweather | M | - |
Newcastle University
| 3 years |
| Melissa Sack | F | - |
University of London
| 1 years |
| Joseph Malel Choge | M | 44 |
University of London
| 2 years |
| Ru Min Zhang | M | 41 |
University of London
| 3 years |
| Matt Burke | M | - |
Newcastle University
| 2 years |
| Fuchsia Curry | F | - |
Newcastle University
| 4 years |
| Gretel Dixon | F | - |
Newcastle University
| 1 years |
| Abbi Dangerfield | F | - |
Newcastle University
| 4 years |
| Hannah Leach | F | - |
Newcastle University
| 3 years |
| Zeng zheng Liu | M | 32 |
University of London
| 1 years |
| Justin Kelley | M | - |
University of London
| 2 years |
| Jo Weir | M | - |
Newcastle University
| 1 years |
| Geordie Wilkes | M | - |
Newcastle University
| 3 years |
| Kader Kieron | M | - |
University of London
| 1 years |
| Ben Horner | M | - |
Newcastle University
| 4 years |
| Kunal Atul Bora | M | 27 |
University of London
| 4 years |
| Joseph Maillard | M | - |
University of London
| 2 years |
| Ben Houston | M | - |
Newcastle University
| 4 years |
| Claire Buckley | F | - |
Newcastle University
| 3 years |
| Freddie Browne | M | - |
Newcastle University
| 4 years |
| Nicholas Dempsey | M | - |
Newcastle University
| 4 years |
| Kieran Francis | M | - |
Newcastle University
| 3 years |
| Tom Rutter | M | - |
Newcastle University
| 4 years |
| Christopher Bottomley | M | - |
Newcastle University
| 4 years |
| Hearth Henrietta | F | - |
Newcastle University
| 4 years |
| Minye Wang | F | 33 |
Newcastle University
| 4 years |
| Wuan Ru Khoo | F | 31 |
Newcastle University
| 4 years |
| Kai Fei Shen | F | 36 |
Newcastle University
| 2 years |
| Ben Castillo-Bernaus | M | - |
Newcastle University
| 4 years |
| Wylie Tollette | M | - |
University of London
| 1 years |
| Yin Shan Hui | F | 56 |
University of London
| 3 years |
| Toby Fenwicke Clennell | M | - |
Newcastle University
| 3 years |
| Dan Skyte | M | - |
Newcastle University
| 3 years |
| Noah Souvignier | M | - |
University of London
| 3 years |
| Hing Lung Lin | M | 30 |
Newcastle University
| 4 years |
| Angela Marie Roper | F | 42 |
University of London
| 1 years |
| Massimo Rocchietti | M | - |
University of London
| 1 years |
| Chao Sun | M | 40 |
Newcastle University
| 1 years |
| Mintra Monsereenusorn | F | - |
University of London
| 1 years |
| Simon Barker | M | - |
Newcastle University
| 3 years |
| Siu Kei Au Yeung | M | 48 |
University of London
| 3 years |
| Nicholas Smith | M | - |
University of London
| 2 years |
| Jie Liu | F | 37 |
Newcastle University
| 1 years |
| David Hexter | M | 75 |
University of London
| 3 years |
| Chi Yung Lee | M | 49 |
University of London
| 2 years |
| Yun jun Lai | M | - |
University of London
| 4 years |
| Scott Bannerman | M | - |
Newcastle University
| 4 years |
| Sau Mei Ng | F | 47 |
University of London
| 3 years |
| Siyang Oh | M | - |
Newcastle University
| 4 years |
| Koblavi Fiagbedzi | M | - |
University of London
| 2 years |
| Xiaolan Wang | F | 35 |
University of London
| 4 years |
| Hari Hook | M | - |
Newcastle University
| 5 years |
| Loudina Erasmus | F | - |
University of London
| 2 years |
| Greg Holmes | M | - |
Newcastle University
| 3 years |
| Gang Wang | M | 57 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | 2 years |
| Ying Liang | F | 51 |
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | - |
| Sam Hields | M | - |
Newcastle University
| 3 years |
| James Jefferson | M | - |
University of London
| 3 years |
| James Bingham | M | - |
Newcastle University
| 3 years |
| Yu Sheng Tay | M | - |
Newcastle University
| 4 years |
| Nathan Dougan | M | - |
Newcastle University
| 4 years |
| Benedetta Mastrolia | F | 28 |
University of London
| 4 years |
| Tian Tian Sun | F | 34 |
University of London
| 1 years |
| Giuliana Cian | F | - |
University of London
| 2 years |
| Carlos Bielsa | M | - |
University of London
| 1 years |
| Hok Wan Tso | M | - |
University of London
| 4 years |
| Afshin Moayed | M | - |
University of London
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 81 | 81.00% |
| China | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tian Wang
- Personal Network
